Quick Answer
DocGo Inc. reported Total Revenue of $322.20 million for fiscal year 2025.
DocGo Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $322.20M -47.7% |
$616.56M -1.2% |
$624.29M +41.7% |
$440.52M +38.2% |
$318.72M +238.7% |
$94.09M |
| Net Income | -$182.40M -1012.4% |
$19.99M +191.5% |
$6.86M -80.2% |
$34.58M +45.7% |
$23.74M +260.4% |
-$14.80M |
| Diluted EPS | -$1.84 -1122.2% |
$0.18 +200.0% |
$0.06 -82.4% |
$0.34 +36.0% |
$0.25 +200.0% |
-$0.25 |
| Total Assets | $217.10M -52.4% |
$455.62M -7.1% |
$490.45M +24.7% |
$393.28M +27.0% |
$309.60M +209.1% |
$100.17M |
| Cash and Equivalents | $51.02M -42.8% |
$89.24M +50.5% |
$59.29M -62.3% |
$157.34M -10.4% |
$175.54M +441.5% |
$32.42M |
| Stockholders Equity | $144.01M -55.1% |
$320.92M +6.7% |
$300.79M +10.1% |
$273.23M +24.4% |
$219.58M +299.3% |
$55.00M -30.7% |
| R&D Expense | $13.56M +17.0% |
$11.59M +6.7% |
$10.86M +101.7% |
$5.38M +62.2% |
$3.32M +179.1% |
$1.19M |
| Operating Income | -$178.03M -720.6% |
$28.69M +90.6% |
$15.05M -31.0% |
$21.83M +42.2% |
$15.36M +204.1% |
-$14.76M |
| Shares Outstanding | 98.64M -3.2% |
101.91M -2.1% |
104.06M +1.6% |
102.41M +2.3% |
100.13M +30.9% |
76.49M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $70.81M | -48.9% | -11.9% |
| Net Income | September 30, 2025 | -$27.77M | -605.1% | -148.9% |
| Diluted EPS | September 30, 2025 | -$0.28 | -660.0% | -154.5% |
| Total Assets | September 30, 2025 | $353.78M | -28.4% | -13.3% |
| Cash and Equivalents | September 30, 2025 | $73.36M | -18.0% | -29.6% |
| Stockholders Equity | September 30, 2025 | $270.53M | -16.8% | -9.0% |
| R&D Expense | September 30, 2025 | $3.19M | +1.5% | +8.0% |
| Operating Income | September 30, 2025 | -$41.98M | -514.1% | -140.1% |
| Shares Outstanding | September 30, 2025 | 97.81M | -4.1% | +0.1% |
- DocGo Inc. reported Total Revenue of $322.20 million for fiscal year 2025.
- DocGo Inc. showed a decrease of -47.7% in Total Revenue compared to the prior fiscal year.
- DocGo Inc. reported Net Income of -$182.40 million for fiscal year 2025.
- DocGo Inc. showed a decrease of -1012.4% in Net Income compared to the prior fiscal year.
- DocGo Inc. reported Diluted EPS of $1.84 per share (loss) for fiscal year 2025.
- DocGo Inc. showed a decrease of -1122.2% in Diluted EPS compared to the prior fiscal year.
- DocGo Inc. reported Total Assets of $217.10 million for fiscal year 2025.
- DocGo Inc. showed a decrease of -52.4% in Total Assets compared to the prior fiscal year.
- DocGo Inc. reported Cash and Equivalents of $51.02 million for fiscal year 2025.
- DocGo Inc. showed a decrease of -42.8% in Cash and Equivalents compared to the prior fiscal year.
- DocGo Inc. reported Stockholders Equity of $144.01 million for fiscal year 2025.
- DocGo Inc. showed a decrease of -55.1% in Stockholders Equity compared to the prior fiscal year.
- DocGo Inc. reported R&D Expense of $13.56 million for fiscal year 2025.
- DocGo Inc. showed an increase of +17.0% in R&D Expense compared to the prior fiscal year.
- DocGo Inc. reported Operating Income of -$178.03 million for fiscal year 2025.
- DocGo Inc. showed a decrease of -720.6% in Operating Income compared to the prior fiscal year.
- DocGo Inc. reported Shares Outstanding of 98.64 million shares for fiscal year 2025.
- DocGo Inc. showed a decrease of -3.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: